Samir M. Kabil

512 total citations
14 papers, 365 citations indexed

About

Samir M. Kabil is a scholar working on Parasitology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Samir M. Kabil has authored 14 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Parasitology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Samir M. Kabil's work include Amoebic Infections and Treatments (5 papers), Parasitic Infections and Diagnostics (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Samir M. Kabil is often cited by papers focused on Amoebic Infections and Treatments (5 papers), Parasitic Infections and Diagnostics (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Samir M. Kabil collaborates with scholars based in Egypt, United States and Italy. Samir M. Kabil's co-authors include Jean‐François Rossignol, E B Keeffe, Asem Elfert, Abdel‐Rahman El‐Zayadi, Joseph A. Murray, Rasha Kamel, Jean François Rossignol, Nizar N. Zein and Mohamed A. Metwally and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Gastrointestinal Endoscopy.

In The Last Decade

Samir M. Kabil

14 papers receiving 340 citations

Peers

Samir M. Kabil
Samir M. Kabil
Citations per year, relative to Samir M. Kabil Samir M. Kabil (= 1×) peers Ali Reza Samarbaf-Zadeh

Countries citing papers authored by Samir M. Kabil

Since Specialization
Citations

This map shows the geographic impact of Samir M. Kabil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir M. Kabil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir M. Kabil more than expected).

Fields of papers citing papers by Samir M. Kabil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir M. Kabil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir M. Kabil. The network helps show where Samir M. Kabil may publish in the future.

Co-authorship network of co-authors of Samir M. Kabil

This figure shows the co-authorship network connecting the top 25 collaborators of Samir M. Kabil. A scholar is included among the top collaborators of Samir M. Kabil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir M. Kabil. Samir M. Kabil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kabil, Samir M., et al.. (2011). A controlled study of nitazoxanide (NTZ) 3 years after treatment of hepatitis C genotype 4.. PubMed. 41(2). 251–61. 2 indexed citations
2.
Rossignol, Jean‐François, et al.. (2008). Clinical trial: randomized, double‐blind, placebo‐controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4. Alimentary Pharmacology & Therapeutics. 28(5). 574–580. 67 indexed citations
3.
Rossignol, Jean‐François, et al.. (2008). 831 RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED TRIAL OF NITAZOXANIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4. Journal of Hepatology. 48. S311–S312. 4 indexed citations
4.
Rossignol, Jean‐François, et al.. (2007). Nitazoxanide in the treatment of amoebiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(10). 1025–1031. 60 indexed citations
5.
Rossignol, Jean‐François, et al.. (2006). Effect of Nitazoxanide in Diarrhea and Enteritis Caused by Cryptosporidium Species. Clinical Gastroenterology and Hepatology. 4(3). 320–324. 94 indexed citations
6.
Kabil, Samir M., et al.. (2001). Low Incidence of Helicobacter pylori Infection in Patients with Duodenal Ulcer and Chronic Liver Disease. Scandinavian Journal of Gastroenterology. 36(5). 479–484. 12 indexed citations
7.
Metwally, Mohamed A., et al.. (2001). A population based study of Helicobacter pylori in Egypt. Gastroenterology. 120(5). A735–A736. 1 indexed citations
8.
Rossignol, Jean‐François, et al.. (2000). Cryptosporidiosis in Benha, study of some recent modalities in diagnosis and treatment.. PubMed. 30(3). 717–25. 11 indexed citations
9.
Kabil, Samir M., et al.. (2000). An open-label clinical study of nitazoxanide in the treatment of human fascioliasis. Current Therapeutic Research. 61(6). 339–345. 17 indexed citations
10.
Kabil, Samir M., et al.. (1998). Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in egypt. Current Therapeutic Research. 59(2). 116–121. 55 indexed citations
11.
Kabil, Samir M., et al.. (1990). The true situation of liver diseases in Egypt with the beginning of declension of virus B hepatitis.. Journal of Tropical Medicine. 1(1). 1–10. 4 indexed citations
12.
Kabil, Samir M., et al.. (1990). ELISA in detection of Entamoeba histolytica antigens in stools.. PubMed. 20(2). 673–6. 2 indexed citations
13.
El‐Zayadi, Abdel‐Rahman, et al.. (1988). Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease. Gastrointestinal Endoscopy. 34(4). 314–317. 28 indexed citations
14.
Kabil, Samir M.. (1976). Host complement in the schistosomal tegument. Transactions of the Royal Society of Tropical Medicine and Hygiene. 79(9). 205–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026